Skip to content

Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements

Simvastatin Vs Therapeutic Lifestyle Changes and Supplements: A Primary Prevention Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00365742
Enrollment
80
Registered
2006-08-17
Start date
2006-04-30
Completion date
2006-06-30
Last updated
2006-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia

Keywords

red yeast rice, pharmaceutical grade fish oil, simvastatin, primary prevention

Brief summary

Randomized trial in a primary prevention population * all participants have high LDL cholesterol Group one will take simvastatin 40 mg/day Group Two will make therapeutic lifestyle changes,and take supplements consisting of red yeast rice and fish oil

Detailed description

This is a randomized primary prevention trial to compare the LDL lowering effects of an alternative regimen to statins(simvastatin) This alternative regimen is over the counter and available at health food stores. The alternative regimen consists of lifestyle changes including a Mediterranean Diet,exercise program, and stress reduction, with red yeast rice 1200 mg twice per day and fish oil 6 grams/day. The second group, run at the same time will take Zocor(simvastatin) 40 mg per day with standard counseling

Interventions

DRUGsimvastatin
DRUGpharmaceutical grade fish oil

Sponsors

Chestnut Hill Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults ages 18-75 yrs, who meet ATP III criteria to be treated for high cholesterol. All participants must be able to exercise and be willing to be randomized to either arm of the study

Exclusion criteria

* No history of bypass surgery, stents, or hx of myocardial infarction. Cannot have uncontrolled hypertension(SBP\>190 or DBP\>100), cannot have known intolerance to one of the study drug

Design outcomes

Primary

MeasureTime frame
LDL-c cholesterol

Secondary

MeasureTime frame
total cholesterol
HDL
Triglycerides
cardiac CRP

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026